Demanol is a derivative of amidopyrine, an analgesic and anti-inflammatory drug that has been discontinued due to safety concerns. The spelling of Demanol follows the English orthographic conventions, with the emphasis on the second syllable. The IPA transcription for Demanol is /dɛməˈnɑl/, with the primary stress on the second syllable indicated by a diacritic mark. While Demanol may no longer be available for use, the spelling and pronunciation of its name serve as a lingering reminder of its past presence in the pharmaceutical market.